Compare Axogen Inc (AXGN) vs Vanguard Ultra Short Bond ETF (VUSB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Vanguard Ultra Short Bond ETF — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while Vanguard Ultra Short Bond ETF trades at $49.67. The key difference: Axogen Inc is trading nearer its 52-week high, Vanguard Ultra Short Bond ETF nearer its low. Which is the better fit depends on your goals.
| AXGN | VUSB | |
|---|---|---|
Market Cap | $2.61B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $48.48 | $50.03 |
52-Week Low | $14.16 | $49.60 |
Enterprise Value | $2.52B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Vanguard Ultra Short Bond ETF
VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.
Read more on VUSB →
